“Outcome of Labetalol and Methyldopa as Oral Antihypertensive Agent in the Treatment of Pregnancy Induced Hypertension”, Mediscope, vol. 8, no. 1, pp. 19–26, Mar. 2021, doi: 10.3329/mediscope.v8i1.52200.